overlay landing page

We have 816 Active VC firms investing in Cannabis on Angels Partners

main investor picture
Mayfield Fund
Investing in Software (Web Marketplace Saas..) &b...
 San Francisco Bay Are..., United States
  • main investor picture
    Paul Kohli
    Vice President of Investment Operations
  • main investor picture
    Vaneeta Varma
    CFO
  • main investor picture
    Yogen Dalal
    Co-Founder
  • main investor picture
    Vikram Godse
    Managing Partner
Investor Picture
Previous Investments
  • Poshmark: $87500000 (Later stage VC)
  • Vexata: $54000000 (Later stage VC)
  • HashiCorp: $40000000 (Later stage VC)
  • InfluxData: $35000000 (Later stage VC)
  • Grove Collaborative: $35000000 (Later stage VC)
  • Stockpile: $30000000 (Later stage VC)
  • BigPanda: $23000000 (Later stage VC)
  • Zipongo: $18000000 (Later stage VC)
  • Arcadia Data: $15000000 (Later stage VC)
  • Berbix: $11570000 (Later stage VC)
  • Mission Bio: $10000000 (Early stage VC)
  • ShiftLeft: $9300000 (Early stage VC)
  • TrustRadius: $5500000 (Later stage VC)
  • M1xchange: $4500000 (Early stage VC)
  • TRIPP: $4000000 (Early stage VC)
  • Phiar Technologies: $3000000 (Seed Round)

Mayfield Fund

San Francisco Bay Area (CA) - Menlo Park, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • Other • IT (& TMT) • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Entertainment (& Sports) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Web Security (& Privacy) • Cloud Services (& Infrastructure) • Developer tools • Future Of Work • Food & Beverage • Human Resources • Impact • Material Science • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction) • SaaS • FoodTech • Healthcare (& Wellness) • Life Science • Mobile • Mobility • Nanotechnology • Oncology • Online Social • Consumer • Pharmaceutical (& Medicine) • Restaurants • Woman Focused • Diagnostics • Productivity

Description

Mayfield Fund is a venture capital firm which specializes in seed, early stage, later stage and growth investments. It invests in companies based in the United States, Europe, India and China operating in the agribusiness, financial services, energy, data, communication, infrastructure, software, internet of things, clean energy, retail, business e-commerce and healthcare sectors. The firm was founded in 1969 and is based in Menlo Park, California.

main investor picture
Polaris Partners
Investing in Software (Web Marketplace Saas..) &b...
 Boston Massachusetts, United States
  • main investor picture
    Peter Flint
    Partner
  • main investor picture
    Gary Swart
    General Partner
  • main investor picture
    Bryce Youngren
    Managing Partner
  • main investor picture
    Jon Flint
    Partner
  • main investor picture
    John Gannon
    General Partner
  • main investor picture
    Alan Crane
    Partner
  • main investor picture
    Paulina Hill
    Partner
  • main investor picture
    Brian Chee
    Managing Partner
  • main investor picture
    Amir Nashat
    Managing Partner
  • main investor picture
    Terry McGuire
    Partner
  • main investor picture
    Dave Barrett
    Managing Partner
  • main investor picture
    David Barrett
    Partner
  • main investor picture
    Dan Lombard
    Partner
  • main investor picture
    Sabrina Chiasson
    Principal
  • main investor picture
    Alexandra Cantley
    Partner
  • main investor picture
    Darren Carroll
    Managing Partner
  • main investor picture
    Ellie McGuire
    Partner
  • main investor picture
    Sharif Vakili
    Associate
  • main investor picture
    Marissa Bertorelli
    Principal
  • main investor picture
    Jay Boland
    Investor
  • main investor picture
    Mark Jacobson
    Vice President
  • main investor picture
    Pat Mulach
    Associate
  • main investor picture
    Maureen St. Pierre
    Analyst
  • main investor picture
    Harold Friedman
    Partner
  • main investor picture
    Brendan Hannigan
    Partner
  • main investor picture
    Darren JD
    Partner
  • main investor picture
    Jeff Presto
    Partner
Investor Picture
Previous Investments
  • Visterra: $23600000 (Series C)
  • Akero Therapeutics: $65000000 (Series A)
  • Neuronetics: $15000000 (Series G)
  • Neuronetics: $34300000 (Series F)
  • Neuronetics: $30000000 (Series E)
  • Visterra: $23100000 (Series C)
  • Visterra: $30000000 (Series B)
  • Visterra: $8100000 (Series A)
  • Visterra: $26100000 (Series A)
  • Visterra: $3300000 (Seed Round)
  • Kala Pharmaceuticals: $68000000 (Series C)
  • Kala Pharmaceuticals: $22500000 (Series B)
  • Kala Pharmaceuticals: $11500000 (Series A)
  • Kala Pharmaceuticals: $7200000 (Private Equity Round)
  • Genocea Biosciences: $30000000 (Series C)
  • Genocea Biosciences: $35000000 (Series B)
  • Genocea Biosciences: (Series B)
  • Vets First Choice: $4000000 (Venture Round)
  • Follica: $135000 (Series B)
  • Follica: $7500000 (Series B)
  • Follica: $11000000 (Series B)
  • Biolex Therapeutics: $30000000 (Series C)
  • Biolex Therapeutics: $36000000 (Series B)
  • Seventh Sense Biosystems: $10000000 (Series C)
  • Seventh Sense Biosystems: $16000000 (Series B)
  • Seventh Sense Biosystems: $10000000 (Series A)
  • Seventh Sense Biosystems: $4500000 (Series A)
  • Quartet: $45000000 (Later stage VC)
  • Lyra Therapeutics: $29500000 (Later stage VC)
  • TARIS Biomedical: $25000000 (Later stage VC)
  • Baxter Planning Systems: $25000000 (Other)
  • Metacrine: $22000000 (Later stage VC)
  • ClearSky Data: $20000000 (Later stage VC)
  • Suono Bio: (Seed Round)
  • TransACT Communications: (Private Equity Round)
  • LastPass: $10000000 (Series B)
  • Pulmatrix: $10000000 (Post Ipo Equity)
  • Pulmatrix: $14000000 (Series B)
  • Pulmatrix: $30000000 (Series B)
  • Pulmatrix: $4000000 (Series A)
  • UpDoc: (Seed)
  • SpineZone: $12000000 (Series A)
  • Livara Health: $15000000 (Series B)
  • Livara Health: $12000000 (Series A)
  • FloQast: $110000000 (Series D)
  • FloQast: $40000000 (Series C)
  • FloQast: $25000000 (Series B)
  • FloQast: $7000000 (Series A)
  • Preply: $35000000 (Series B)
  • Preply: $10000000 (Series A)
  • Stensul: $16000000 (Series B)
  • Cobalt: $29000000 (Series B)
  • Swiftly: $3000000 (Seed)
  • Qstream: $15000000 (Series B)
  • B12: $12000000 (Series A)
  • Envoy: $3000000 (Seed)
  • CliQr Technologies: $20000000 (Series C)
  • Tome Biosciences: $210000000 (Series A)
  • Seismic Therapeutic: $120000000 (Series B)
  • Seismic Therapeutic: $100000000 (Series A)
  • Dyno Therapeutics: $100000000 (Series A)
  • Dyno Therapeutics: $9000000 (Seed)
  • Pandion Therapeutics: $58000000 (Series A)
  • YourBio Health: $10000000 (Series C)
  • YourBio Health: $16000000 (Series B)
  • YourBio Health: $10000000 (Series A)
  • YourBio Health: $5000000 (Series A)
  • Navitor Pharmaceuticals: $33000000 (Series B)
  • Navitor Pharmaceuticals: $24000000 (Series A)
  • T2 Biosystems: $40000000 (Series E)
  • T2 Biosystems: $23000000 (Series D)
  • T2 Biosystems: $15000000 (Series C)
  • T2 Biosystems: $11000000 (Series B)
  • T2 Biosystems: $6000000 (Series A)
  • Cerulean Pharma: $13000000 (Private Equity)
  • Cerulean Pharma: $15000000 (Series D)
  • Cerulean Pharma: $24000000 (Series C)
  • Cerulean Pharma: $10000000 (Series B)
  • Cerulean Pharma: $8000000 (Series B)
  • Cerulean Pharma: $12000000 (Series A)
  • Cerulean Pharma: $2000000 (Series Unknown)
  • Ocular Therapeutix: $14000000 (Series D)
  • Ocular Therapeutix: $6000000 (Series C)
  • Ocular Therapeutix: $15000000 (Series C)
  • Hydra Biosciences: $22000000 (Series D)
  • Hydra Biosciences: $34000000 (Series C)
  • Hydra Biosciences: $19000000 (Series B)
  • Hydra Biosciences: $9000000 (Series A)
  • Adnexus: $16000000 (Series C)
  • Adnexus: $27000000 (Series B)
  • Adnexus: $13000000 (Series A)
  • Noetik: $40000000 (Series A)
  • ByHeart: $95000000 (Series C)
  • ByHeart: $70000000 (Series A)
  • Vico Therapeutics: $72000000 (Series B)
  • Vico Therapeutics: $31000000 (Series A)
  • Engine Biosciences: $27000000 (Series A)
  • Engine Biosciences: $43000000 (Series A)
  • Larkspur Biosciences: $36000000 (Series A)
  • Volastra Therapeutics: $60000000 (Series A)
  • Volastra Therapeutics: $32000000 (Seed)
  • Volastra Therapeutics: $12000000 (Seed)
  • Thirty Madison: $140000000 (Series C)
  • Thirty Madison: $47000000 (Series B)
  • Keeps: $47000000 (Series B)
  • Glympse Bio: $47000000 (Series B)
  • Glympse Bio: $22000000 (Series A)
  • SQZ Biotech: $65000000 (Series D)
  • SQZ Biotech: (Series D)
  • SQZ Biotech: $72000000 (Series C)
  • SQZ Biotech: $16000000 (Series B)
  • SQZ Biotech: $5000000 (Series A)
  • QurAlis: $42000000 (Series A)
  • Cardurion Pharmaceuticals: (Series A)
  • Quentis Therapeutics: $48000000 (Series A)
  • Cohere Health: $50000000 (Series C)
  • Cohere Health: $36000000 (Series B)
  • Tausight: $6000000 (Series Unknown)
  • Tausight: $20000000 (Series A)
  • Simon Data: $54000000 (Series D)
  • Simon Data: $30000000 (Series C)
  • Simon Data: $20000000 (Series B)
  • Sonrai Security: $50000000 (Series C)
  • Sonrai Security: $20000000 (Series B)
  • Sonrai Security: $19000000 (Series A)
  • OM1: $85000000 (Series D)
  • OM1: $50000000 (Series C)
  • OM1: $21000000 (Series B)
  • Armorblox: $30000000 (Series B)
  • Recurly: $20000000 (Series C)
  • Recurly: $12000000 (Series B)
  • Recurly: $6000000 (Series A)
  • Recurly: $2000000 (Seed)
  • Lob: $23000000 (Series B)
  • Lob: $7000000 (Series A)
  • Lob: $2000000 (Seed)
  • InsideSales: $50000000 (Series D)
  • InsideSales: $61000000 (Series D)
  • InsideSales: $100000000 (Series C)
  • Bitium: $6000000 (Series Unknown)
  • Bitium: $7000000 (Series A)
  • Upland Localytics: $35000000 (Series D)
  • Upland Localytics: $16000000 (Series C)
  • Upland Localytics: $6000000 (Series B)
  • Vhoto: $750000 (Seed)
  • Vhoto: $2000000 (Seed)
  • Egnyte: $30000000 (Series D)
  • Egnyte: $16000000 (Series C)
  • Egnyte: $6000000 (Series A)
  • Logentries: $10000000 (Series A)
  • Logentries: $1000000 (Seed)
  • Phytel: $14000000 (Series Unknown)
  • Imprivata: $15000000 (Series C)
  • Imprivata: $12000000 (Series B)
  • Imprivata: $4000000 (Series A)
  • Imprivata: $14000000 (Series A)
  • Archivas: $12000000 (Series C)
  • Archivas: $10000000 (Series B)
  • Archivas: $6000000 (Series A)
  • LogMeIn: $10000000 (Series B)
  • Integrian: $13000000 (Series B)
  • FIRE1: $120000000 (Series Unknown)
  • Satellite Bio: $82000000 (Series A)
  • Montis Biosciences: $9000000 (Seed)
  • Tectonic Therapeutic: $130000000 (Post Ipo Equity)
  • Tectonic Therapeutic: $80000000 (Series A)
  • Ankyra: $45000000 (Series B)
  • Invivyd: $340000000 (Series C)
  • Invivyd: $80000000 (Series B)
  • Invivyd: $50000000 (Series A)
  • Iora Health: $130000000 (Series F)
  • Iora Health: $100000000 (Series E)
  • Iora Health: $75000000 (Series D)
  • Iora Health: $28000000 (Series C)
  • Iora Health: $14000000 (Series B)
  • Arsanis: $46000000 (Series D)
  • Arsanis: $20000000 (Series B)
  • Arsanis: $10000000 (Series A)
  • Alector: $30000000 (Series D)
  • Alector: $32000000 (Series C)
  • Alector: (Series A)
  • Editas Medicine: $120000000 (Series B)
  • Editas Medicine: $43000000 (Series A)
  • PULMATRIX, INC.: $10000000 (Post Ipo Equity)
  • PULMATRIX, INC.: $14000000 (Series B)
  • PULMATRIX, INC.: $30000000 (Series B)
  • PULMATRIX, INC.: $4000000 (Series A)
  • Arsenal Medical: $16000000 (Series Unknown)
  • Arsenal Medical: $10000000 (Series Unknown)
  • Arsenal Medical: $13000000 (Series B)
  • 480 Biomedical: $12000000 (Series C)
  • 480 Biomedical: $15000000 (Series A)
  • Pymetrics: $3000000 (Seed)
  • WikiCell Designs: $10000000 (Series A)
  • Adimab: $14000000 (Series F)
  • Adimab: $8000000 (Series D)
  • Adimab: $4000000 (Series C)
  • Adimab: $3000000 (Series B)
  • Adimab: $6000000 (Series A)
  • Adimab: $6000000 (Series A)
  • Trevena: $35000000 (Series B)
  • Trevena: $24000000 (Series A)
  • Acceleron Pharma: $10000000 (Series Unknown)
  • Acceleron Pharma: $31000000 (Series C)
  • Acceleron Pharma: $30000000 (Series B)
  • MicroCHIPS: $17000000 (Series Unknown)
  • Remon Medical Technologies: $10000000 (Series C)
  • Remon Medical Technologies: $16000000 (Series C)
  • Remon Medical Technologies: $10000000 (Series A)
  • TRex Bio: $84000000 (Series B)
  • TRex Bio: $26000000 (Series A)
  • Sunbird Bio: $14000000 (Series Unknown)
  • EpiBiologics: $73000000 (Series A)
  • Auron Therapeutics: $48000000 (Series A)
  • Matter Neuroscience: $26000000 (Seed)
  • Freenome: $250000000 (Series Unknown)
  • Freenome: $300000000 (Series D)
  • Freenome: $270000000 (Series C)
  • Freenome: $160000000 (Series B)
  • Freenome: $7000000 (Series A)
  • Freenome: $65000000 (Series A)
  • Jnana Therapeutics: $110000000 (Series C)
  • Jnana Therapeutics: $50000000 (Series A)
  • Scholar Rock: $210000000 (Post Ipo Equity)
  • Scholar Rock: $47000000 (Series C)
  • Scholar Rock: $36000000 (Series B)
  • Scholar Rock: $20000000 (Series A)
  • Dewpoint Therapeutics: $150000000 (Series C)
  • Dewpoint Therapeutics: $77000000 (Series B)
  • Dewpoint Therapeutics: $60000000 (Series A)
  • Kojin Therapeutics: $60000000 (Series A)
  • Primmune Therapeutics: $27000000 (Series A)
  • 1366 Technologies: $18000000 (Series E)
  • 1366 Technologies: $15000000 (Series C)
  • 1366 Technologies: $6000000 (Series B)
  • 1366 Technologies: $20000000 (Series B)
  • AgBiome: $65000000 (Series C)
  • AgBiome: $35000000 (Series B)
  • AgBiome: $18000000 (Series Unknown)
  • AgBiome: $18000000 (Series A)
  • Sofregen Medical: $6000000 (Series A)
  • Olivo Laboratories LLC: (Seed)
  • Selecta Biosciences: $38000000 (Series E)
  • Selecta Biosciences: $20000000 (Private Equity)
  • Selecta Biosciences: $15000000 (Series C)
  • Selecta Biosciences: $15000000 (Series B)
  • aTyr Pharma: $49000000 (Series D)
  • aTyr Pharma: $23000000 (Series C)
  • aTyr Pharma: $12000000 (Series C)
  • aTyr Pharma: $11000000 (Series B)
  • Promedior: $22000000 (Series D)
  • Promedior: $14000000 (Series A)
  • Fate Therapeutics: $36000000 (Series B)
  • Fate Therapeutics: $12000000 (Series A)
  • Sun Catalytix: $10000000 (Series B)
  • Sun Catalytix: $1000000 (Seed)
  • BIND Therapeutics: $12000000 (Series C)
  • BIND Therapeutics: $16000000 (Series B)
  • BIND Therapeutics: $3000000 (Series A)
  • Pervasis Therapeutics: $17000000 (Series C)
  • Pervasis Therapeutics: $10000000 (Series Unknown)
  • Pervasis Therapeutics: $12000000 (Series B)
  • Pervasis Therapeutics: $2000000 (Series A)
  • Pervasis Therapeutics: $500000 (Seed)
  • Avila Therapeutics: $30000000 (Series B)
  • Athenix: $10000000 (Series D)
  • Athenix: $13000000 (Series C)
  • Athenix: $13000000 (Series B)
  • Athenix: $8000000 (Series A)
  • Tessa Therapeutics: $130000000 (Series A)
  • EGenesis: $130000000 (Series C)
  • Emergency Reporting: (Private Equity)
  • August Bioservices: $65000000 (Series B)
  • August Bioservices: $24000000 (Series A)
  • Nomad Health: $110000000 (Series Unknown)
  • Nomad Health: $63000000 (Series D)
  • Nomad Health: $34000000 (Series C)
  • Nomad Health: $12000000 (Series B)
  • BlackThorn Therapeutics: $76000000 (Series B)
  • KenSci: $22000000 (Series B)
  • US HealthVest: $50000000 (Series B)
  • US HealthVest: $36000000 (Series A)
  • First Opinion: $6000000 (Series A)
  • Suneva Medical: $15000000 (Debt Financing)
  • Suneva Medical: $20000000 (Series B)
  • Apnex Medical: $20000000 (Series C)
  • Apnex Medical: $14000000 (Series B)
  • Apnex Medical: $16000000 (Series A)
  • BridgePoint Medical: $9000000 (Series C)
  • BridgePoint Medical: $6000000 (Series Unknown)
  • BridgePoint Medical: $10000000 (Series B)
  • BridgePoint Medical: $1000000 (Series A)
  • Respicardia: $27000000 (Series C)
  • Respicardia: $21000000 (Series B)
  • Free & Clear: $10000000 (Series Unknown)
  • Transoma Medical: $5000000 (Series D)
  • Transoma Medical: $13000000 (Series C)
  • Transoma Medical: $13000000 (Series B)
  • Transoma Medical: $12000000 (Series A)
  • Ultreo: $18000000 (Series C)
  • Ultreo: $11000000 (Series C)
  • UltraShape Ltd. (Syneron Medical): $15000000 (Series Unknown)
  • Archus Orthopedics: $35000000 (Series C)
  • Archus Orthopedics: $18000000 (Series B)
  • TransACT: (Private Equity)
  • Iridium Technology: (Private Equity)
  • NetRate Systems: (Series Unknown)
  • Baxter Planning: $25000000 (Series Unknown)
  • Cityworks: $15000000 (Series Unknown)
  • Dealer Spike: (Series Unknown)
  • Strata Health: (Series Unknown)
  • Alimera Sciences: $5000000 (Series C)
  • Alimera Sciences: $30000000 (Series C)
  • Alimera Sciences: $32000000 (Series B)
  • Alimera Sciences: $27000000 (Series A)
  • e-Rewards: $60000000 (Private Equity)
  • e-Rewards: $15000000 (Series Unknown)
  • Cushcraft Corp.: (Series Unknown)
  • SmartMail Services: $45000000 (Series C)
  • Living Proof: $30000000 (Series C)
  • Living Proof: $16000000 (Series B)
  • Living Proof: $7000000 (Series A)
  • EXOS: $23000000 (Series Unknown)
  • EXOS: $5000000 (Series B)
  • EXOS: (Series A)
  • JibJab Bros Studios: $8000000 (Series C)
  • JibJab Bros Studios: $3000000 (Series B)
  • JibJab Bros Studios: $6000000 (Series A)

Polaris Partners

Boston Massachusetts, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Sales (& Marketing) • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Analytics • Cloud Services (& Infrastructure) • Future Of Work • Human Resources • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Mobile • Consumer • Pharmaceutical (& Medicine) • Diagnostics

Description

Polaris Venture Partners is a venture capital firm that invests in seed, early, later and expansion stage companies operating in the technology and healthcare sectors. The firm was founded in 1996 and is based in Boston, Massachusetts.

main investor picture
Congruent Ventures
Investing in Software (Web Marketplace Saas..) &b...
 San Francisco Califor..., United States
  • main investor picture
    Joshua Posamentier
    Managing Partner
  • main investor picture
    Abe Yokell
    Managing Partner
  • main investor picture
    Christina O'Conor
    Partner
  • main investor picture
    Abraham Yokell
    Partner
Investor Picture
Previous Investments
  • Flywheel Software: $12000000 (Series C)
  • Flywheel Software: $14800000 (Series B)
  • Flywheel Software: $7300000 (Venture Round)
  • Omnidian, Inc.: $5100000 (Seed Round)
  • Phase Genomics: $1000000 (Seed Round)
  • Energetic Insurance, Inc.: $630000 (Other)
  • Bellwether Coffee:
  • Hopthru:
  • Flywheel (Application Software): $760000 (Early Stage VC)
  • Leap (Media and Information Services): (Angel)
  • Meati Foods: $50000000 (Series B)
  • Meati Foods: $25000000 (Series A)
  • Leap: $12000000 (Series Unknown)
  • AMP Robotics: $91000000 (Series C)
  • AMP Robotics: $55000000 (Series B)
  • AMP Robotics: $16000000 (Series A)
  • AMP Robotics: (Seed)
  • AMP: $91000000 (Series D)
  • AMP: $91000000 (Series C)
  • AMP: $55000000 (Series B)
  • AMP: $16000000 (Series A)
  • AMP: (Seed)
  • Demex: $10000000 (Series A)
  • Camus Energy: $10000000 (Series A)
  • Camus Energy: $16000000 (Series A)
  • Omnidian: $25000000 (Series Unknown)
  • Omnidian: $33000000 (Series B)
  • Omnidian: $15000000 (Series A)
  • Omnidian: $5000000 (Seed)
  • Pano: $17000000 (Series A)
  • Evergrow: $7000000 (Seed)
  • Evergrow: $7000000 (Seed)
  • Qnovo: $24000000 (Series C)
  • Qnovo: $9000000 (Series B)
  • Qnovo: $7000000 (Series A)
  • Qnovo: $1000000 (Seed)
  • MilkRun: $6000000 (Series A)
  • Thrilling: $9000000 (Series A)
  • Amply Power: $13000000 (Series A)
  • Amply Power: $2000000 (Seed)
  • Amply Power: $1000000 (Seed)
  • Blueprint Power: $4000000 (Series A)
  • Renovate America: $90000000 (Private Equity)
  • Renovate America: $50000000 (Private Equity)
  • Renovate America: $6000000 (Series C)
  • EcoFactor: $7000000 (Series C)
  • EcoFactor: $10000000 (Series B)
  • EcoFactor: $9000000 (Series A)
  • EcoFactor: $4000000 (Series A)
  • Flywheel: $12000000 (Series C)
  • Flywheel: $15000000 (Series B)
  • Flywheel: $7000000 (Series Unknown)
  • Streetline: $10000000 (Series D)
  • Streetline: $25000000 (Series C)
  • Streetline: $15000000 (Series B)
  • REPOWER by Solar Universe: $7000000 (Series B)
  • Enphase Energy: $40000000 (Series Unknown)
  • Enphase Energy: $23000000 (Series Unknown)
  • Eka Systems: $19000000 (Series D)
  • Eka Systems: $13000000 (Series C)
  • Forterra: $75000000 (Series B)
  • Dispatch Goods: $4000000 (Seed)
  • Applied Carbon: $22000000 (Series A)
  • Fervo Energy: $240000000 (Series D)
  • Lydian: $12000000 (Seed)
  • VEIR: $25000000 (Series A)
  • VEIR: $11000000 (Series A)
  • Robigo: $7000000 (Seed)
  • Parallel Systems: $50000000 (Series A)
  • Parallel Systems: $4000000 (Seed)
  • Meati: $50000000 (Series B)
  • Meati: $28000000 (Series A)
  • Meati: $5000000 (Seed)
  • QuantumScape: (Series Unknown)

Congruent Ventures

San Francisco California - San Francisco Bay Area, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • CleanTech • A.I. (& Big Data) • Cannabis • Autonomous vehicles (& Cars) • Food & Beverage • Impact • Robotics • DeepTech • FoodTech • Healthcare (& Wellness) • Investment Management • Life Science • Mobility • Online Social • Consumer • Pharmaceutical (& Medicine) • Oil & Gas (& Mining) • Industrials • 3D Printing • Diagnostics

Description

Congruent Ventures is a venture capital firm that invests in early stage sustainable technology companies. It is based in San Francisco, California and was founded in 2016.

main investor picture
Vulcan Capital
Investing in Software (Web Marketplace Saas..) &b...
 Bellevue Washington ,..., United States
  • main investor picture
    Abhishek Agrawal
    Senior Associate
  • main investor picture
    YB Choi
    Investor
  • main investor picture
    Stuart Nagae
    Investor
Investor Picture
Previous Investments
  • UNITY Biotechnology: $35000000 (Series B)
  • Oxygen Media: $100000000 (Later stage VC)
  • Caspian Networks: $85000000 (Later stage VC)
  • solarisBank: $67490000 (Later stage VC)
  • Cytokinetics, Inc.: $40000000 (Later stage VC)
  • PortalPlayer: $22000000 (Later stage VC)
  • Clean Fund: $15000000 (Later stage VC)
  • Versive: $12700000 (Later stage VC)
  • IFILM: $10000000 (Other)
  • Rocket Network: $9300000 (Later stage VC)
  • ICON Technology (Homebuilding): $9000000 (Early stage VC)
  • Make.TV Inc.: $8500000 (Later stage VC)
  • Pointy: $6000000 (Early stage VC)
  • Nomadic: $6000000 (Seed Round)
  • Against Gravity: $5000000 (Later stage VC)
  • Ryff: $5000000 (Early stage VC)
  • Blokable, Inc.: $4886194 (Later stage VC)
  • Grab: $2000000 (Seed Round)
  • Taunt: $1700000 (Seed Round)
  • Matcherino: $1500000 (Seed Round)
  • eStyle: $1139000 (Later stage VC)
  • TicketGuardian LLC: $500000 (Other)
  • Calxeda: $55000000 (Series C)
  • Omeros: $20000000 (Post Ipo Equity)
  • Infinia: $12000000 (Series Unknown)
  • Infinia: $7000000 (Series B)
  • Infinia: $50000000 (Series B)
  • Infinia: $10000000 (Series A)
  • Radar Networks: $13000000 (Series B)
  • Radar Networks: $5000000 (Series A)
  • AdaptX: $10000000 (Series B)
  • AdaptX: $6000000 (Series A)
  • Blokable: $6000000 (Series Unknown)
  • Rebellyous Foods: $20000000 (Series B)
  • Kevala: $12000000 (Series A)
  • Nifty Games: $26000000 (Series B)
  • Gentem: $10000000 (Series A)
  • Gentem: $4000000 (Seed)
  • AI.Reverie: $6000000 (Seed)
  • AI.Reverie: (Seed)
  • Prophia: $10000000 (Series A)
  • CivicEye: $12000000 (Series A)
  • Rad Power Bikes: $150000000 (Series D)
  • Rad Power Bikes: $150000000 (Series C)
  • Rad Power Bikes: $25000000 (Series B)
  • Voodle: $6000000 (Series A)
  • Nautilus Biotechnology: $76000000 (Series B)
  • Pixvana, Inc.: $14000000 (Series A)
  • Pixvana, Inc.: $6000000 (Seed)
  • 4INFO: $8000000 (Series Unknown)
  • 4INFO: $14000000 (Series Unknown)

Vulcan Capital

Bellevue Washington - California - Seattle, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • PropTech • Other • IT (& TMT) • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • IoT (& Wearables) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Gaming (& eSports) • Cloud Services (& Infrastructure) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Robotics • Real Estate (& Construction) • Healthcare (& Wellness) • LegalTech • Mobility • Consumer

Description

Vulcan Capital is a private equity and venture capital firm and investment arm of Paul Allen based in Seattle, Washington. The firm focuses on investing in all stages of corporate development through leveraged buyouts, growth capital, turnarounds and early-stage venture capital. The firm invests in the financial services, internet technology, life sciences, media, communication and consumer sectors. It was established in 2003 and operates as an investment arm of Vulcan.

main investor picture
Panakes Partners
Investing in BioTech • HealthTech (& Fitness...
 Milan, Italy
  • main investor picture
    Diana Saraceni
    Founder and Managing Partner
  • main investor picture
    Alessio Beverina
    Founder and Managing Partner
  • main investor picture
    Alessio Piuma
    Associate
  • main investor picture
    Barbara Castellano
    Principal
  • main investor picture
    Fabrizio Landi
    President, Founder and Managing Partner
  • main investor picture
    Giacomo Piccinini
    Analyst
  • main investor picture
    Michele Alloni
    Analyst
  • main investor picture
    Laura Brolis
    CFO
Investor Picture
Previous Investments
  • Salvia BioElectronics: $24860000 (Later stage VC)
  • SamanTree Medical: $9380000 (Early stage VC)
  • Aileens Pharma: $3510000 (Early stage VC)

Panakes Partners

Milan, Italy

Contact this investors  
Investing In

BioTech • HealthTech (& Fitness) • Cannabis • Medical Devices (& Hospital Services) • Life Science • Pharmaceutical (& Medicine) • Diagnostics

Description

Panakes Partners is a venture Capital investor that invests in the health sector. The firm was founded in 2015 and is based in Milano, Italy.

main investor picture
Upfront Ventures
Investing in Software (Web Marketplace Saas..) &b...
 California , Paris , ..., United States
  • main investor picture
    Mark Suster
    General Partner
  • main investor picture
    Aditi Maliwal
    Partner
  • main investor picture
    Nick Kim
    General Partner
  • main investor picture
    Kevin Zhang
    Partner
  • main investor picture
    Kobie Fuller
    General Partner
  • main investor picture
    Yves Sisteron
    Advisor
  • main investor picture
    Alice Cheng
    Associate
  • main investor picture
    Dana Kibler
    Advisor
  • main investor picture
    Stuart Lander
    COO
  • main investor picture
    Josh Mittler
    Advisor
  • main investor picture
    Seksom Suriyapa
    General Partner
  • main investor picture
    Kesar Varma
    Investor
  • main investor picture
    AJ Herrera
    Investor
  • main investor picture
    Jacques Sisteron
    Investor
  • main investor picture
    Katherine Zhang
    Investor
Investor Picture
Previous Investments
  • ALL DAY MEDIA: $2300000 (Seed Round)
  • uBeam: $10000000 (Series A)
  • ChowNow: $1000000 (Series A)
  • Rally Rd.: $7000000 (Series A)
  • GOAT Group: $60000000 (Series C)
  • HopSkipDrive: $7400000 (Series A)
  • HopSkipDrive: $10200000 (Series A)
  • Happy Returns: $4000000 (Series A)
  • Deliv: $28000000 (Series B)
  • Deliv: $4500000 (Series A)
  • Deliv: $6900000 (Series A)
  • DRAFT: $3500000 (Series A)
  • Retention Science: $7000000 (Series A)
  • thredUP: $25000000 (Series D)
  • Chromatik: $2000000 (Seed Round)
  • DroneBase: $20000000 (Venture Round)
  • DroneBase: $12500000 (Series C)
  • DroneBase: $7500000 (Series C)
  • DroneBase: $12000000 (Series B)
  • DroneBase: $6800000 (Series A)
  • Pinwheel: $20000000 (Series A)
  • Pinwheel: $7000000 (Seed Round)
  • Rally: $30000000 (Series B)
  • Rally: $7000000 (Series A)
  • Loupe: $3000000 (Seed Round)
  • Landline: $3900000 (Seed Round)
  • inVia Robotics: $20000000 (Series B)
  • Rival: $25000000 (Series B)
  • Rubica: $9000000 (Series A)
  • Pragma: $12000000 (Series A)
  • Pragma: $4200000 (Seed Round)
  • Solve HQ: $20000000 (Series Unknown)
  • Stage: $5000000 (Seed)
  • Dayslice: $6000000 (Seed)
  • Endgame: $30000000 (Series B)
  • Endgame: $5000000 (Seed)
  • Endgame: $5000000 (Seed)
  • Eterneva: $10000000 (Series A)
  • Britive: $10000000 (Series A)
  • Britive: $5000000 (Seed)
  • Territory Foods: $22000000 (Series B)
  • Territory Foods: $4000000 (Series A)
  • Territory Foods: $4000000 (Series A)
  • Territory Foods: $7000000 (Series A)
  • Territory Foods: $5000000 (Seed)
  • Stem Disintermedia: $10000000 (Series Unknown)
  • Stem Disintermedia: $8000000 (Series A)
  • Stem Disintermedia: $5000000 (Seed)
  • Fleetsmith: $30000000 (Series B)
  • Fleetsmith: $8000000 (Series A)
  • Skylar: $8000000 (Series A)
  • Skylar: $3000000 (Seed)
  • The Wing: $75000000 (Series C)
  • Qordoba: $12000000 (Series B)
  • Qordoba: $5000000 (Series A)
  • Parachute Home: $30000000 (Series C)
  • Parachute Home: $4000000 (Seed)
  • Parachute Home: $800000 (Seed)
  • Strive: $4000000 (Seed)
  • Waldo Photos: $5000000 (Seed)
  • LeoLabs: $13000000 (Series A)
  • AirMap: $26000000 (Series B)
  • Path: $18000000 (Series A)
  • Path: $5000000 (Seed)
  • Bionaut Labs: $43000000 (Series B)
  • Bionaut Labs: $20000000 (Series A)
  • CertifyOS: $15000000 (Series A)
  • CertifyOS: $5000000 (Seed)
  • Tellie: $10000000 (Series A)
  • Omni Creator Products: $4000000 (Seed)
  • Pragma Platform: $22000000 (Series B)
  • Pragma Platform: $12000000 (Series A)
  • Pragma Platform: $4000000 (Seed)
  • Rula: $18000000 (Series A)
  • Rula: $5000000 (Seed)
  • Stray Bombay: $5000000 (Seed)
  • Seriously: $18000000 (Series A)
  • Seriously: $5000000 (Seed)
  • Seriously: $3000000 (Seed)
  • Seriously: $2000000 (Seed)
  • Grove: $2000000 (Seed)
  • OurSky: $10000000 (Seed)
  • Jiko: $29000000 (Series C)
  • Jiko: $40000000 (Series B)
  • Jiko: $40000000 (Series A)
  • Jiko: $8000000 (Seed)
  • Reveleer: $65000000 (Series Unknown)
  • Reveleer: $6000000 (Series C)
  • Reveleer: $3000000 (Series B)
  • Reveleer: $3000000 (Series A)
  • Reveleer: $3000000 (Series A)
  • Reveleer: $1000000 (Series A)
  • Reveleer: $3000000 (Series A)
  • Apeel Sciences: $250000000 (Series D)
  • Apeel Sciences: $70000000 (Series C)
  • Apeel Sciences: $33000000 (Series B)
  • Apeel Sciences: $6000000 (Series A)
  • NuORDER: $15000000 (Series C)
  • NuORDER: $8000000 (Series B)
  • NuORDER: $3000000 (Series Unknown)
  • NuORDER: $8000000 (Series A)
  • NuORDER: $4000000 (Seed)
  • Teforia Company: $12000000 (Series A)
  • Teforia Company: $5000000 (Seed)
  • Nima: $9000000 (Series A)
  • Nima: $4000000 (Seed)
  • SOOT: $7000000 (Seed)
  • Cordial: $50000000 (Series C)
  • Cordial: $15000000 (Series B)
  • Cordial: $7000000 (Series A)
  • Hairtelligence: $5000000 (Seed)
  • Martie: $3000000 (Seed)
  • Bevy: $40000000 (Series C)
  • Bevy: $15000000 (Series B)
  • Bevy: $6000000 (Series A)
  • SureSale: $7000000 (Series A)
  • MetaCX: $14000000 (Series Unknown)
  • UserTesting: $46000000 (Series C)
  • Open Raven: $20000000 (Series B)
  • Arcade: $14000000 (Series A)
  • Arcade: $3000000 (Seed)
  • Renew: $8000000 (Seed)
  • Finary: $3000000 (Seed)
  • Clair: $5000000 (Seed)
  • PowerToFly: $7000000 (Series A)
  • Modern Animal: $46000000 (Series D)
  • Safe: $1000000 (Pre Seed)
  • Heroic Story: $6000000 (Seed)
  • Queer Spaces: $1000000 (Convertible Note)
  • Remento: $3000000 (Seed)
  • Invoca: $83000000 (Series F)
  • Invoca: $56000000 (Series E)
  • Invoca: $30000000 (Series D)
  • Invoca: $22000000 (Series C)
  • Invoca: $3000000 (Series Unknown)
  • Invoca: $4000000 (Series B)
  • Invoca: $4000000 (Series A)
  • Secfense: $2000000 (Seed)
  • VADE: $4000000 (Seed)
  • Density: $130000000 (Series D)
  • Density: $51000000 (Series C)
  • Density: $4000000 (Series A)
  • GumGum: $75000000 (Series E)
  • GumGum: $22000000 (Series D)
  • GumGum: $26000000 (Series C)
  • GumGum: $7000000 (Series B)
  • GumGum: $3000000 (Series A)
  • Nanit: $25000000 (Series C)
  • Nanit: $21000000 (Series B)
  • Nanit: $14000000 (Series B)
  • Nanit: $8000000 (Series A)
  • Nanit: $7000000 (Seed)
  • InfoSum: $15000000 (Series A)
  • InfoSum: $5000000 (Seed)
  • InfoSum: $3000000 (Seed)
  • MakeSpace: $45000000 (Series E)
  • MakeSpace: $30000000 (Corporate Round)
  • MakeSpace: $30000000 (Series C)
  • MakeSpace: $18000000 (Series B)
  • MakeSpace: $8000000 (Series A)
  • MakeSpace: $2000000 (Seed)
  • SOLVE: $20000000 (Series Unknown)
  • Aircam: $7000000 (Seed)
  • Tact.ai: $27000000 (Series C)
  • Tact.ai: $15000000 (Series B)
  • SonicEnergy™: $20000000 (Series B)
  • SonicEnergy™: $10000000 (Series A)
  • Skurt: (Convertible Note)
  • Skurt: $10000000 (Series A)
  • Skurt: $1000000 (Seed)
  • MyTime: $6000000 (Series C)
  • MyTime: $11000000 (Series B)
  • MyTime: $3000000 (Series A)
  • Osmo: $18000000 (Series B)
  • Osmo: $12000000 (Series A)
  • Osmo: $3000000 (Seed)
  • ALL DAY: $2000000 (Seed)
  • Projector App: $4000000 (Seed)
  • Ferris: $2000000 (Seed)
  • Wheel: $2000000 (Seed)
  • Vidme: $3000000 (Seed)
  • Epoxy: $7000000 (Series A)
  • Epoxy: $2000000 (Seed)
  • REDEF: $2000000 (Seed)
  • Adly: $2000000 (Series Unknown)
  • Adly: $5000000 (Series B)
  • Adly: $500000 (Seed)
  • Neverware: $1000000 (Seed)
  • Maker Studios: $36000000 (Series C)
  • Maker Studios: $2000000 (Series B)
  • Maker Studios: $2000000 (Series A)
  • Gravity: $11000000 (Series B)
  • ecomom: $4000000 (Series A)
  • ecomom: $1000000 (Angel)
  • awe.sm: $4000000 (Series Unknown)
  • awe.sm: $1000000 (Seed)
  • Burstly: $6000000 (Series Unknown)
  • Pose.com: $3000000 (Series A)
  • Pose.com: $2000000 (Series Unknown)
  • Treehouse: $600000 (Seed)
  • GameSalad: $6000000 (Series A)
  • GameSalad: $1000000 (Series A)

Upfront Ventures

California - Paris - Santa Monica, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • AgroTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Sales (& Marketing) • Entertainment (& Sports) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Blockchain (& Cryptos) • Web Security (& Privacy) • Gaming (& eSports) • Advertising • Analytics • Cloud Services (& Infrastructure) • Developer tools • Future Of Work • Human Resources • Impact • Insurance (& InsurTech) • Local commerce • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Payments • Aerospace (& Defense) • SaaS • DeepTech • Healthcare (& Wellness) • Life Science • Mobility • Nanotechnology • Online Social • Consumer • Pharmaceutical (& Medicine) • Woman Focused • Diagnostics

Description

Most Interested In

Interactive media (gaming, VR/AR, livestreaming, etc.), healthcare, AI, computer vision, IoT, natural sciences

main investor picture
Square Peg Capital Pty Ltd.
Investing in Software (Web Marketplace Saas..) &b...
 Massachusetts, United States
  • main investor picture
    Catherine Ferdon
    Head of Marketing and Brand
Investor Picture
Previous Investments
  • ClimaCell Inc.: (early stage)
  • LifeBEAM: (mid stage)
  • Ready4: (mid stage)
  • Square Peg Capital: (mid stage)
  • Internet of Things, Digital Health, Social Apps:
  • ooVoo:

Square Peg Capital Pty Ltd.

Massachusetts, United States

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • PropTech • Other • IT (& TMT) • Hospitality (& Events) • Media • Education • BioTech • AgroTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Sales (& Marketing) • Cosmetics (& Fashion) • Entertainment (& Sports) • IoT (& Wearables) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Blockchain (& Cryptos) • Web Security (& Privacy) • Gaming (& eSports) • Advertising • Analytics • AR/VR • Autonomous vehicles (& Cars) • Cloud Services (& Infrastructure) • Developer tools • Future Of Work • Food & Beverage • GovTech • Human Resources • Impact • Insurance (& InsurTech) • Local commerce • Logistics (& Distribution) • Material Science • Medical Devices (& Hospital Services) • Messaging • Payments • Robotics • Mobile Apps • Aerospace (& Defense) • Real Estate (& Construction)

Description

Partner at Square Peg Capital

Partner at Square Peg Capital

main investor picture
    E8
    Investing in IT (& TMT) • CleanTech • C...
     Seattle, U.S.A.
    Investor Picture
    Previous Investments
    • StormSensor: $1200000
    • StormSensor:

    E8

    Seattle, U.S.A.

    Contact this investors  
    Investing In

    IT (& TMT) • CleanTech • Cannabis

    Description

    Element 8 is a member organization of private and accredited angel investors. The firm invests in early stage companies operating in the clean technology, energy and information technology sectors. It is based in Seattle, Washington and was founded in 2006.

    main investor picture
    Berkeley SkyDeck
    Investing in Education • BioTech • Hard...
     San Francisco Bay Are..., United States
    • main investor picture
      Bree Cahill
      Advisor
    • main investor picture
      Suzanne Levi
    • main investor picture
      Sibyl Chen
      Other
    Investor Picture
    Previous Investments
    • Talkwheel: (Seed Round)
    • Embee Mobile: (Venture Round)

    Berkeley SkyDeck

    San Francisco Bay Area (CA), United States

    Contact this investors  
    Investing In

    Education • BioTech • Hardware (& Manufacturing) • Energy • A.I. (& Big Data) • Cannabis • Analytics • Autonomous vehicles (& Cars) • Material Science • Aerospace (& Defense) • DeepTech • Incubators • Life Science • Nanotechnology • Pharmaceutical (& Medicine) • Semiconductors • Diagnostics

    Description

    UC Berkeley's official startup accelerator. We help Cal entrepreneurs and transformational startups from outside of the US. Bring us your moonshot!

    main investor picture
      Ollerhead Capital
      Investing in PropTech • Other • Educati...
       Toronto, Canada
      Investor Picture
      Previous Investments
      • Xtraction Services: $2800000
      • Xtraction Services:

      Ollerhead Capital

      Toronto, Canada

      Contact this investors  
      Investing In

      PropTech • Other • Education • FinTech (& Financials services) • Hardware (& Manufacturing) • HealthTech (& Fitness) • Cannabis • Real Estate (& Construction) • Healthcare (& Wellness)

      Description

      Ollerhead Capital is a merchant banking and financing advisory firm based in Toronto, Canada. Founded in 1997, the firm provides advisory services in the areas of corporate finance, project management, strategic planning, financial modeling, business plan review and evaluation of acquisitions.

      main investor picture
      Forward Ventures
      Investing in IT (& TMT) • Media • BioTe...
       San Diego, United States
      • main investor picture
        Caroline Barberio
        CFO
      • main investor picture
        Stuart Collinson
        Partner
      • main investor picture
        Standish Fleming
        Founding Managing Partner
      Investor Picture
      Previous Investments
      • Ambit Biosciences: $50000000 (Later stage VC)
      • Syndax Pharmaceuticals: $26600000 (Later stage VC)
      • Nereus Pharmaceuticals: $20000000 (Later stage VC)
      • Viracta Therapeutics: $18400000 (Later stage VC)
      • HemaQuest Pharmaceuticals: $12000000 (Later stage VC)
      • Affinium Pharmaceuticals: $11900000 (Other)
      • SpotQA: $3230000 (Early stage VC)
      • Virtuoso: $3230000 (Early stage VC)
      • Somatix:

      Forward Ventures

      San Diego, United States

      Contact this investors  
      Investing In

      IT (& TMT) • Media • BioTech • HealthTech (& Fitness) • Cannabis • Logistics (& Distribution) • Incubators • Life Science • Oncology • Pharmaceutical (& Medicine) • Diagnostics

      Description

      Forward Ventures is a venture capital firm based in San Diego, California and was founded in 1990. The firm invests in early and late stage companies operating in the life science, healthcare, pharmaceutical and medical device sectors.

      main investor picture
        Alturus Strategic Capital Partners
        Investing in CleanTech • Cannabis
         Dallas, U.S.A.
        Investor Picture
        Previous Investments
        • Baseline Energy Services:

        Alturus Strategic Capital Partners

        Dallas, U.S.A.

        Contact this investors  
        Investing In

        CleanTech • Cannabis

        Description

        Alturus Strategic Capital Partners is a Dallas, Texas based strategic capital provider that focuses on middle-market companies. The firm invests in business services, consumer, distribution and logistics, energy services and specialty manufacturing sectors.

        Join the community!
        Connect with investors & startup founders

        Overview of the Cannabis Industry

        Overview of the Cannabis Industry

        The Cannabis industry involves the cultivation, production, and sale of cannabis and cannabis-derived products for medicinal, recreational, and industrial purposes.

        Market Growth

        The global cannabis market was valued at approximately $20.5 billion in 2020 and is projected to reach $90.4 billion by 2026, growing at a CAGR of 28.0%.

        Drivers of Industry Growth

        The growth of this industry is driven by the increasing legalization and acceptance of cannabis for medicinal and recreational use, advancements in cultivation and extraction technologies, and the growing demand for cannabis-based products.

        Impact on Society

        The cannabis industry has a significant impact on society by providing new medical treatments, creating jobs, and generating tax revenue. Medicinal cannabis is used to treat various conditions, including chronic pain, epilepsy, multiple sclerosis, and anxiety, providing patients with an alternative to traditional pharmaceuticals.

        Recreational Cannabis

        Recreational cannabis offers consumers a legal and regulated option for adult use, reducing the illegal market and associated criminal activities.

        Industrial Uses of Cannabis

        The industrial use of cannabis, particularly hemp, includes the production of textiles, biofuels, and construction materials, promoting sustainability and innovation.

        Effect of COVID-19 on Industry Adoption

        The COVID-19 pandemic has accelerated the growth of the cannabis industry, as consumers seek alternative wellness products and governments recognize the economic potential of cannabis legalization.

        Challenges in the Industry

        However, the industry faces challenges related to regulatory compliance, stigma, and the need for research on the long-term effects of cannabis use.

        Future of the Cannabis Industry

        Despite these challenges, the potential benefits of cannabis innovations are significant, and continued investment and policy support are essential for driving growth in this sector. As the cannabis industry continues to evolve, it will play a crucial role in shaping the future of medicine, recreation, and industrial applications, promoting economic development and societal well-being.

        How to connect with VC firms in the Cannabis Industry?

        Target Firms

        To connect with VCs in the Cannabis sector, target firms such as Privateer Holdings, Casa Verde Capital, and The Arcview Group. Research their investment portfolios to understand their focus areas and tailor your approach accordingly.

        Networking Opportunities

        Networking through industry conferences, cannabis summits, and expos can provide opportunities to meet VC partners. Engaging in these events allows you to establish connections and showcase your startup to potential investors.

        Effective Pitching

        When pitching, focus on demonstrating the market potential, technological innovation, and scalability of your cannabis solution. Be prepared to discuss your business model, regulatory compliance, and how you plan to achieve profitability.

        Demo Days Participation

        Participating in demo days hosted by cannabis accelerators or incubators can help you showcase your product to a broader audience of VCs. These events provide a platform to highlight your solution’s unique value proposition.

        Crafting a Compelling Story

        Crafting a compelling story about your product’s impact and the problem it solves will resonate well with VC investors who are looking for high-growth potential startups. Emphasize the transformative potential of your solution.

        Comprehensive Pitch Deck

        Following up with a comprehensive pitch deck that includes market analysis, go-to-market strategy, and potential exit opportunities can further strengthen your case. A detailed and well-prepared pitch deck is crucial for attracting investor interest.

        Strategic Partnerships

        Highlighting any strategic partnerships or collaborations with dispensaries or cannabis brands can also add weight to your pitch. These partnerships validate your solution and demonstrate market acceptance.

        Presenting a Strong Team

        Ensuring that you present a well-rounded team with expertise in both cannabis industry regulations and product development will appeal to VCs looking for capable execution of your vision. A strong and experienced team is essential for successful implementation and growth.

        Most active VC firms in the Cannabis industry?

        Overview

        To connect with VCs in the Cannabis sector, target firms such as Sequoia Capital, Andreessen Horowitz, and Casa Verde Capital. These firms have a strong track record of investing in successful cannabis startups.

        Sequoia Capital

        Sequoia Capital, known for backing companies like Eaze and Pax Labs, focuses on high-growth potential and market disruption. They are interested in cannabis startups that can significantly impact the market.

        Andreessen Horowitz

        Andreessen Horowitz, with investments in companies like Flow Kana and Tokken, looks for innovative cannabis solutions that can scale globally. Their portfolio highlights transformative cannabis technologies.

        Casa Verde Capital

        Casa Verde Capital, founded by Snoop Dogg, seeks out startups with strong brand presence and scalable business models in the cannabis industry. They prioritize companies that can achieve significant market penetration.

        Research and Connection

        To connect with these VCs, research their investment portfolios and identify partners who have shown interest in your industry. Attend industry conferences, cannabis summits, and cannabis tech forums where these VCs are likely to be present.

        Participating in Demo Days

        Participating in demo days hosted by cannabis accelerators or incubators can also provide exposure. These events offer opportunities to showcase your product to a broader audience of potential investors.

        Pitching to VCs

        When pitching to VCs, emphasize your startup’s market opportunity, technological innovation, and scalability. Be prepared to discuss your business model, customer acquisition strategies, and revenue projections in detail.

        Crafting a Compelling Story

        Crafting a compelling story about your product’s impact and the problem it solves will resonate well with VC investors. Highlighting the unique aspects and potential of your solution is crucial.

        Comprehensive Pitch Deck

        Follow up with a comprehensive pitch deck that includes market analysis, competitive landscape, and potential exit opportunities. This will provide VCs with a clear understanding of your business and its potential.

        Strategic Partnerships

        Highlighting any strategic partnerships or collaborations with major cannabis companies or regulatory bodies can also add weight to your pitch. These relationships can demonstrate market validation and growth potential.

        Presenting a Strong Team

        Ensure that you present a well-rounded team with expertise in both cannabis technology and business development. A capable team is essential for executing your vision and achieving success.

        Comprehensive Guides to Raising Funds Online

        By clicking on "Create Account" you accept our terms of service

        Already have an account?
        Login
        Mike testimonial

        Michael Colin - Founder of The MVMT



        "We met the perfect Angel Investor within the Angels Partners Investors' Community. We received a $250,000 check after 2 months of discussions with investors on the platform."

        Taylor Testimonial

        Taylor Matter - Founder & CEO, Hurdle Apparel



        "Raising Capital for a consumer venture can be rather difficult and Angels Partners helped connect the dots and helped us meet 2 investors who investors $200,000 in our brand."

        founder clement

        Clément Perrot - Co-Founder & CEO of Prynt



        "Met really good investors who invested in Prynt, that I wouldn’t have met otherwise. Angels Partners helped us close our round quicker and with the right people."


        Create An Account
        Copyright © 2026 - All trademarks and copyrights belong to their respective owners.
        proof notifcation
        32 New StartupsStarted their fundraisingover the last 7 days